• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

TMXLU:LX

24.6400 USD 0.2700 1.11%

As of 03:26:11 ET on 08/19/2014.

Snapshot for Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund (TMXLU)

Open: 24.6400 High - Low: 24.6400 - 24.6400 Primary Exchange: Luxembourg
Volume: 0 52-Week Range: 17.7700 - 25.7700 Beta vs NBI: 0.9554

ETF Chart for TMXLU

No chart data available.
  • TMXLU:LX 24.6400
  • 1D
  • 1M
  • 1Y
24.3700
Interactive TMXLU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TMXLU

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equity securities of biotechnology companies and discovery research firms, located in the US and other countries (with market capitalisation of less than $2 billion).

Inception Date: Telephone: 352-46-66-67-1
Managers: EVAN MCCULLOCH
Web Site: www.franklintempleton.lu

Fundamentals for TMXLU

NAV -
Assets (M) (on 2014-07-31) 2,939.9200
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for TMXLU

No dividends reported

Performance for TMXLU

1-Month +16.61% 1-Year +37.96%
3-Month +21.20% 3-Year +40.85%
Year To Date +18.46% 5-Year +26.08%
Expense Ratio 2.71

Top Fund Holdings for TMXLU

Filing Date: 04/30/2014
Name Position Value % of Total
Gilead Sciences Inc 4,065,000 319,061,850 10.929%
Biogen Idec Inc 774,540 222,385,925 7.618%
Amgen Inc 1,357,100 151,655,925 5.195%
Celgene Corp 2,005,000 147,377,525 5.048%
Regeneron Pharmaceuticals Inc 492,000 146,069,880 5.003%
Medivation Inc 2,116,100 127,410,381 4.364%
Alexion Pharmaceuticals Inc 567,200 89,731,040 3.074%
Incyte Corp 1,741,200 84,552,672 2.896%
Illumina Inc 606,400 82,379,440 2.822%
Vertex Pharmaceuticals Inc 1,018,100 68,925,370 2.361%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil